The chart below shows the treatment the participants took.
18 participants
• Budesonide, glycopyrronium, and formoterol fumarate
combined into a single treatment
• 320 μg of budesonide
• 14.4 μg of glycopyrronium
• 9.6 μg of formoterol fumarate
• Through an inhaler
• 1 dose during the study
What happened during this study?
The study started in May 2019 and ended in March 2020. Each participant was
in the study for about 6 weeks, but the entire study took 10 months to finish.
The chart below shows what happened during the study.
Before the participants While the participants took After the participants took
took the study drugs the study drugs the study drugs
1 visit 1 visit
The study doctors checked to make The participants stayed The study doctors called the
sure the participants could join the overnight at their study site. participants to ask them how
study. On the second day, they they were feeling.
took 1 dose of budesonide,
The study doctors:
glycopyrronium, and
did a physical examination and formoterol fumarate
checked the participants’ vital combined.
signs
took urine samples
checked the participants’ heart
health using an
electrocardiogram, also called
an ECG
checked the participants’ lung
health
asked the participants about
their medical history, how they
were feeling, and what
medicines they were taking
Up to 1 month 2 days About 2 weeks after treatment
4 | Clinical Study Results